Summary
Xulong Wang is a Statistical Science Director with 11 years of experience bridging biostatistics, statistical genetics, and data science to advance therapies from preclinical research through registrational clinical trials. Based in Boston, he has led statistical strategy for Phase I–III studies and regulatory submissions—most recently driving pivotal analyses for selinexor across hematologic and solid tumor indications. His background spans industry and research roles at AstraZeneca, Karyopharm, Merck, and The Jackson Laboratory, where he applied causal modeling, genomics, and machine learning to target ID, biomarker development, and precision-medicine efforts. Trained as a PhD biomedical engineer, he combines deep computational genetics expertise with hands-on regulatory experience, and his GitHub motto “Keep Calm and Kary on” hints at a pragmatic, steady approach to high-stakes drug development.
11 years of coding experience
15 years of employment as a software developer
Bachelor's degree Engineering Physics/Applied Physics, Bachelor's degree Engineering Physics/Applied Physics at Xidian University
Ph.D Biomedical Engineering, Ph.D Biomedical Engineering at Shanghai Jiao Tong University
Chinese, English